Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/28/2014US8871971 Protection of normal cells
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871935 Crystalline pharmaceutical and methods of preparation and use thereof
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871925 Compositions of novel carbohydrate drug for treatment of human diseases
10/28/2014US8871903 Palladium catalyzed reactions executed on solid-phase peptide synthesis supports for the production of self-assembling peptides embedded with complex organic electronic subunits
10/28/2014US8871816 Methods for producing vaccine adjuvants
10/28/2014US8871815 Therapeutic compounds
10/28/2014US8871814 Grease-like gel for repelling insects and preventing undesirable behavior in hoofed animals
10/28/2014US8871813 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/28/2014US8871812 Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis
10/28/2014US8871811 Permeation enhancers for topical formulations
10/28/2014US8871810 Treating critically ill patients with intravenous ibuprofen
10/28/2014US8871809 Diclofenac topical formulation
10/28/2014US8871806 Methods for preventing flea allergy dermatitis in companion animals
10/28/2014US8871805 Compound, composition and uses thereof
10/28/2014US8871802 Naphthoquinones for disease therapies
10/28/2014US8871801 Method of treating acquired perforating dermatosis with cantharidin
10/28/2014US8871800 Statin and omega-3 fatty acids for reduction of Apo-B levels
10/28/2014US8871799 Iminochromene anti-viral compounds
10/28/2014US8871798 Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
10/28/2014US8871797 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871795 Pharmaceutical oral telmisartan solution
10/28/2014US8871794 Small-molecule agonists for type-2 orexin receptor
10/28/2014US8871793 Metaxalone cocrystals
10/28/2014US8871792 Neprilysin inhibitors
10/28/2014US8871791 Narcotic emulsion formulations for treatment of cancer pain
10/28/2014US8871790 Heterocyclic modulators of lipid synthesis
10/28/2014US8871789 Method of preventing or treating viral infection
10/28/2014US8871788 Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
10/28/2014US8871787 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester
10/28/2014US8871786 Azaindazole amide compounds as CCR1 receptor antagonists
10/28/2014US8871785 Antiviral phosphonate analogs
10/28/2014US8871784 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/28/2014US8871783 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C
10/28/2014US8871782 Alkoxy substituted imidazoquinolines
10/28/2014US8871781 Methods and compositions for treating a subject for a lymphatic malformation
10/28/2014US8871780 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof
10/28/2014US8871779 Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
10/28/2014US8871778 Substituted pyrimidine compounds and their use as SYK inhibitors
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871775 Compounds
10/28/2014US8871774 Inhibitors of influenza viruses replication
10/28/2014US8871773 Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
10/28/2014US8871772 Therapeutic methods and compounds
10/28/2014US8871771 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871768 Certain chemical entities, compositions and methods
10/28/2014US8871767 2-arylimidazo[1,2-B]pyridazine, 2-phenylimidazo[1,2-A]pyridine, and 2-phenylimidazo[1,2-A]pyrazine derivatives
10/28/2014US8871766 Heterocyclic compounds
10/28/2014US8871765 Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one derivatives as poly (ADP-ribose) polymerase-1 inhibitors
10/28/2014US8871764 Lisofylline analogs and methods for use
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871762 Plant disease controlling composition and method for controlling plant disease
10/28/2014US8871761 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/28/2014US8871759 Inhibitors of hepatitis C virus replication
10/28/2014US8871758 Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
10/28/2014US8871757 6-and 7-amino isoquinoline compounds and methods for making and using the same
10/28/2014US8871755 Alkene azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/28/2014US8871754 Compounds and compositions for the treatment of parasitic diseases
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871752 Method for modulating stem cell growth
10/28/2014US8871751 Compositions and methods relating to nuclear hormone and steroid hormone receptors including inhibitors of estrogen receptor alpha-mediated gene expression and inhibition of breast cancer
10/28/2014US8871750 Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus
10/28/2014US8871749 Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative
10/28/2014US8871747 Urea and thiourea derivatives
10/28/2014US8871746 Antiviral drugs for treatment of arenavirus infection
10/28/2014US8871745 Proteasome inhibitors
10/28/2014US8871744 Compounds and methods for selectively targeting tumor-associated mucins
10/28/2014US8871742 Composition and method for treating connective tissue damage
10/28/2014US8871741 Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate
10/28/2014US8871740 Use of polysaccharides for treating stress and anxiety
10/28/2014US8871739 Solid acid catalyzed hydrolysis of cellulosic materials
10/28/2014US8871737 Substituted nucleotide analogs
10/28/2014US8871736 Maintenance of platelet inhibition during antiplatelet therapy
10/28/2014US8871735 Methods and compositions for providing cardiac protection
10/28/2014US8871731 Micro-RNA for the regulation of cardiac apoptosis and contractile function
10/28/2014US8871730 Chemical modification of short small hairpin RNAs for inhibition of gene expression
10/28/2014US8871729 Treatment of CNS conditions
10/28/2014US8871728 Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
10/28/2014US8871727 Ectoparasiticidal methods and formulations
10/28/2014US8871726 C-aryl glucoside derivative, preparation method therefor, and use thereof
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871718 Transglutaminase inhibitors and methods of use thereof
10/28/2014US8871707 Elastin producing fibroblast formulations and methods of using the same
10/28/2014US8871509 Nanoparticle-based gene delivery systems
10/28/2014US8871507 Method of inhibiting apolipoprotein-E expression comprising administering a triarylmethyl amine compound
10/28/2014US8871506 Methods for treating cardio pulmonary diseases with NO group compounds
10/28/2014US8871436 Immunostimulatory oligonucleotides and uses thereof
10/28/2014US8871284 Method and compositions for preserving wine
10/28/2014US8871281 Treatment of oral pharyngeal dysphagia
10/28/2014US8871276 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
10/28/2014US8871275 Extended release compositions comprising tolterodine
10/28/2014US8871274 Pharmaceutical formulations for dry powder inhalers
10/28/2014US8871273 Method for producing granules
10/28/2014US8871271 Method and composition for pharmaceutical product
10/28/2014US8871269 Method for the preparation of controlled release formulations
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 7860